{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T22:17:01Z","timestamp":1775081821557,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/00324"],"award-info":[{"award-number":["PI17\/00324"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jaut.2023.103013","type":"journal-article","created":{"date-parts":[[2023,2,26]],"date-time":"2023-02-26T23:03:16Z","timestamp":1677452596000},"page":"103013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Thyroid cells from normal and autoimmune thyroid glands suppress T lymphocytes proliferation upon contact revealing a new regulatory inhibitory type of interaction independent of PD1\/PDL1"],"prefix":"10.1016","volume":"136","author":[{"given":"Daniel","family":"\u00c1lvarez-Sierra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nerea","family":"S\u00e1nchez-Gaona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Cruz Cobo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alba","family":"Escriche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Abad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aroa","family":"G\u00f3mez-Brey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Bello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enric","family":"Caubet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d3scar","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carles","family":"Zaf\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmela","family":"Iglesias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Petit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco Antonio","family":"Fern\u00e1ndez-Sanmart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"Mart\u00ednez-Gallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Pujol-Borrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2023.103013_bib1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s12020-012-9703-2","article-title":"The incidence and prevalence of thyroid autoimmunity","volume":"42","author":"McLeod","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.jaut.2023.103013_bib2","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1210\/jc.2013-2409","article-title":"The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis","volume":"99","author":"Madariaga","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jaut.2023.103013_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00521","article-title":"Thyroid autoimmunity: role of anti-thyroid antibodies in thyroid and extra-thyroidal diseases","volume":"8","author":"Fr\u00f6hlich","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2023.103013_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cell.2007.06.033","article-title":"Multistep pathogenesis of autoimmune disease","volume":"130","author":"Goodnow","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2023.103013_bib5","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1073\/pnas.93.6.2260","article-title":"Checkpoints in the progression of autoimmune disease: lessons from diabetes models","volume":"93","author":"Andr\u00e9","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jaut.2023.103013_bib6","article-title":"Graves' disease","volume":"6","author":"Davies","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.jaut.2023.103013_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1210\/er.2013-1055","article-title":"Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity","volume":"35","author":"McLachlan","year":"2014","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jaut.2023.103013_bib8","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2013-2912","article-title":"Iodine contributes to thyroid autoimmunity in humans by unmasking a cryptic epitope on thyroglobulin","volume":"98","author":"Latrofa","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jaut.2023.103013_bib9","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0140-6736(83)90629-3","article-title":"Role of aberrant hla-dr expression and antigen presentation in induction of endocrine autoimmunity","volume":"322","author":"Bottazzo","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2023.103013_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ni.1817","article-title":"Mechanisms maintaining peripheral tolerance","volume":"11","author":"Mueller","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2023.103013_bib11","article-title":"Rethinking peripheral T cell tolerance: checkpoints across a T cell's journey","author":"ElTanbouly","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2023.103013_bib12","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","article-title":"Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation","volume":"192","author":"Freeman","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2023.103013_bib13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/85330","article-title":"PD-L2 is a second ligand for PD-1 and inhibits T cell activation","volume":"2","author":"Latchman","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2023.103013_bib14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nri.2017.108","article-title":"The diverse functions of the PD1 inhibitory pathway","volume":"18","author":"Sharpe","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2023.103013_bib15","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.4049\/jimmunol.179.8.5064","article-title":"PD-1 regulates self-reactive CD8+ T cell responses to antigen in lymph nodes and tissues","volume":"179","author":"Keir","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2023.103013_bib16","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0140-6736(83)90628-1","article-title":"Aberrant expression of hla-dr antigen on thyrocytes in graves' disease: relevance for autoimmunity","volume":"322","author":"Hanafusa","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2023.103013_bib17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0896-8411(05)80055-1","article-title":"Expression of intercellular adhesion molecule-1 in thyroid follicular cells in autoimmune, non-autoimmune and neoplastic diseases of the thyroid gland: discordance with HLA","volume":"5","author":"Tolosa","year":"1992","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2023.103013_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jaut.2011.01.002","article-title":"Analysis of the cumulative changes in Graves' disease thyroid glands points to IFN signature, plasmacytoid DCs and alternatively activated macrophages as chronicity determining factors","volume":"36","author":"Ruiz-Riol","year":"2011","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2023.103013_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.05.013","article-title":"Analysis of the PD-1\/PD-L1 axis in human autoimmune thyroid disease: insights into pathogenesis and clues to immunotherapy associated thyroid autoimmunity","volume":"103","author":"\u00c1lvarez-Sierra","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2023.103013_bib20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrendo.2016.205","article-title":"Cancer immunotherapy-immune checkpoint blockade and associated endocrinopathies","volume":"13","author":"Byun","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.jaut.2023.103013_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2012.00133","article-title":"Thyroid cancer cell lines: an overview","volume":"3","author":"Saiselet","year":"2012","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.jaut.2023.103013_bib22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0896-8411(91)90155-6","article-title":"De novo HLA Class II and enhanced HLA Class I molecule expression in SV40 transfected human thyroid epithelial cells","volume":"4","author":"Belfiore","year":"1991","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2023.103013_bib23","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1158\/2326-6066.CIR-14-0040","article-title":"Vitro characterization of the anti-PD-1 antibody nivolumab, BMS-936558, and in vivo toxicology in non-human primates","volume":"2","author":"Wang","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jaut.2023.103013_bib24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/cyto.a.21010","article-title":"Interpretation of cellular proliferation data: avoid the panglossian","volume":"79","author":"Roederer","year":"2011","journal-title":"Cytometry"},{"key":"10.1016\/j.jaut.2023.103013_bib25","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jaut.2023.103013_bib26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/febs.15570","article-title":"A guide to assessing cellular senescence in vitro and in vivo","volume":"288","author":"Gonz\u00e1lez-Gualda","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.jaut.2023.103013_bib27","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1365-2249.1991.tb05634.x","article-title":"Detection of interleukin-6 and interleukin-1 production in human thyroid epithelial cells by non-radioactive in situ hybridization and immunohistochemical methods","volume":"83","author":"Zheng","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2023.103013_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11762","article-title":"Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis","volume":"7","author":"Ruhland","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jaut.2023.103013_bib29","first-page":"265","article-title":"Interferon-y induces HLA-DR expression by thyroid epithelium","volume":"61","author":"Todd","year":"1985","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2023.103013_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2002796","article-title":"Selective effects of PD-1 on Akt and ras pathways regulate molecular components of the cell cycle and inhibit T cell proliferation","volume":"5","author":"Patsoukis","year":"2012","journal-title":"Sci. Signal."},{"key":"10.1016\/j.jaut.2023.103013_bib31","article-title":"CD3+CD4-CD8- (Double-Negative) T cells in inflammation, immune disorders and cancer","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2023.103013_bib32","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1182\/blood-2006-10-050625","article-title":"New differentiation pathway for double-negative regulatory T cells that regulates the magnitude of immune responses","volume":"109","author":"Zhang","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2023.103013_bib33","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.4049\/jimmunol.1202929","article-title":"Agonistic anti-CD40 induces thyrocyte proliferation and promotes thyroid autoimmunity by increasing CD40 expression on thyroid epithelial cells","volume":"190","author":"Kayes","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2023.103013_bib34","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1210\/en.2016-1609","article-title":"CD40 signaling in graves disease is mediated through canonical and noncanonical thyroidal nuclear factor kB activation","volume":"158","author":"Lee","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.jaut.2023.103013_bib35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1158\/0008-5472.CAN-09-1882","article-title":"Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer","volume":"70","author":"Pan","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.jaut.2023.103013_bib36","series-title":"Cross-Linking of the CD40 Ligand on Human CD4+ T Lymphocytes Generates a Costimulatory Signal that Up-Regulates IL-4 Synthesis'","author":"Heloisa Blotta","year":"1996"},{"key":"10.1016\/j.jaut.2023.103013_bib37","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1158\/2326-6066.CIR-14-0150","article-title":"Galectin-3 shapes antitumor immune responses by suppressing CD8 T cells via LAG-3 and inhibiting expansion of plasmacytoid dendritic cells","volume":"3","author":"Kouo","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jaut.2023.103013_bib38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.it.2016.10.002","article-title":"TIGIT: a key inhibitor of the cancer immunity cycle","volume":"38","author":"Manieri","year":"2017","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jaut.2023.103013_bib39","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.4049\/jimmunol.1103627","article-title":"The TIGIT\/CD226 Axis regulates human T cell function","volume":"188","author":"Lozano","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2023.103013_bib40","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.immuni.2007.08.015","article-title":"Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation","volume":"27","author":"Jiang","year":"2007","journal-title":"Immunity"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841123000227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841123000227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:29:44Z","timestamp":1760257784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841123000227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":40,"alternative-id":["S0896841123000227"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2023.103013","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thyroid cells from normal and autoimmune thyroid glands suppress T lymphocytes proliferation upon contact revealing a new regulatory inhibitory type of interaction independent of PD1\/PDL1","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2023.103013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103013"}}